Stem cell derived exosome therapy for clinical management of lung damage in critically-ill corona viral pneumonia patients
Implementing Organization
Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST)
Visit
Principal Investigator
Dr Naresh Kasoju
Scientist, Sree Chitra Tirunal Institute for Medical Sciences &Technology (SCTIMST), Thiruvananthapuram
Project Overview
This study hypothesized that the immuno-modulatory and the reparative properties of MSC-derived exosomal fractions will aid in controlling the cytokine storm and the lung tissue regeneration in the critically ill COVID-19 patients.
Scientist, Sree Chitra Tirunal Institute for Medical Sciences &Technology (SCTIMST), Thiruvananthapuram
Accessibility Controls